Cathy Prescott Insider Profile
4 Followers
Cathy Prescott, Director at SkinBioTherapeutics, holds 181.11K shares in SkinBioTherapeutics (Ticker: GB:SBTX). Most recently, Cathy Prescott Bought 62,500 shares of SkinBioTherapeutics on Dec 16, 2022 for an estimated value of 10.00K .
Cathy Prescott's Trading History
| SBTXSkinBioTherapeutics | Dec 16, 2022 | Director | Informative Buy | 10.00K | £8.60K | |||||||||||||||||||||||||||||
GB:SBTX Insider Shares: 181.11K (11.55%)
| ||||||||||||||||||||||||||||||||||
You May Also Like
Cathy Prescott insider profile FAQ
What is the percentage of profitable transactions made by Cathy Prescott?
The percentage of profitable transactions made by Cathy Prescott is 33%.
What is the average return per transaction made by Cathy Prescott?
The average return per transaction made by Cathy Prescott is 64.30%.
What stocks does Cathy Prescott hold?
Cathy Prescott holds: GB:SBTX stocks.
What was Cathy Prescott’s latest transaction?
Cathy Prescott’s latest transaction was an Informative Buy of 10.00K .
What was Cathy Prescott's most profitable transaction?
Cathy Prescott’s most profitable transaction was an Informative Buy of GB:SBTX stock on October 14, 2020. The return on the trade was 245.80%.
What is Cathy Prescott's role in SkinBioTherapeutics?
Cathy Prescott's role in SkinBioTherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
